Biomedical Engineering
Targeting mechanobiological mediators of fibrosis
November 28, 2017
4:30 p.m. - 5:30 p.m.
Doherty Hall A302
Biomedical Engineering
November 28, 2017
4:30 p.m. - 5:30 p.m.
Doherty Hall A302
Daniel Tschumperlin, Ph.D.
Associate Professor
Vice Chair, Department of Physiology & Biomedical Engineering
Mayo Clinic College of Medicine
Tissue fibrosis contributes to progressive functional decline and end stage disease in the lungs, heart, kidneys and liver. Fibrotic tissue remodeling is accompanied by stiffening of the extracelluar matrix, and recent work indicates that fibroblasts respond to matrix stiffening in a positive-feedback loop of cellular activation and matrix deposition. Identifying the cellular and molecular pathways that drive fibroblast mechanoresponses may thus open new opportunities for treating fibrosis across multiple organs. Furthermore, delineating the homeostatic interactions that normally keep fibroblast activation in check during normal tissue function and healthy wound healing may open new perspectives on how fibrosis arises, and how tissue homeostasis might be restored. In this seminar I will focus on YAP and TAZ as mechanobiological mediators that promote fibroblast activation and fibrosis in the lung, and a novel GPCR-based approach for targeting fibroblasts to reverse cellular activation and arrest fibrosis progression.
January 24 2019
12:00 PM - 1:00 PM
Scott Institute for Energy Innovation
NREL's Tony Markel on creating a more efficient and secure energy system
5201 Scott Hall
January 25 2019
1:00 PM - 2:00 PM
Mechanical Engineering
Seminar with Dr. Marco Castaldi
100 Porter Hall
February 19 2019
12:00 PM - 1:20 PM
Scott Institute for Energy Innovation
NETL Director Brian Anderson on his role at the DOE Lab
5201 Scott Hall
February 26 2019
12:00 PM - 1:20 PM
Scott Institute for Energy Innovation
Cleantech Open Northeast Director Beth Zonis on innovation and cleantech
5201 Scott Hall